SCHEMBL21687759

SCHEMBL21687759

N#Cc1cc(-c2cc(C#N)ccc2[Si](c2ccccc2)(c2ccccc2)c2ccccc2)cc(-n2c3ccccc3c3ccccc32)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
METAP2 P50579 1/20 0.35
KDM4E B2RXH2 2/20 0.35
ATM Q13315 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
CYP1A2 P05177 6/20 0.32
CYP3A4 P08684 5/20 0.32
MEN1 O00255 4/20 0.32
ALDH1A1 P00352 4/20 0.32
KMT2A Q03164 4/20 0.32
LMNA P02545 4/20 0.32
CYP2D6 P10635 4/20 0.32
CLK4 Q9HAZ1 4/20 0.32
TSHR P16473 3/20 0.32
CYP2C19 P33261 3/20 0.32
HSD17B10 Q99714 3/20 0.32
MAPK1 P28482 2/20 0.32
CYP2C9 P11712 1/20 0.32
TP53 P04637 2/20 0.32
TDP2 O95551 2/20 0.32
ELANE P08246 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21687513 0.97 METAP2 (0.33) METAP2KDM4EATML3MBTL1CYP1A2
SCHEMBL21687552 0.91 KDM4E (0.35) METAP2KDM4EATML3MBTL1CYP1A2
SCHEMBL21687979 0.91 KDM4E (0.36) METAP2KDM4EATML3MBTL1CYP1A2
SCHEMBL21687904 0.90 KDM4E (0.33) METAP2KDM4EATML3MBTL1CYP1A2
SCHEMBL21687458 0.89 KDM4E (0.38) METAP2KDM4EATML3MBTL1CYP1A2
SCHEMBL21687820 0.88 ATM (0.40) METAP2KDM4EATML3MBTL1MEN1
SCHEMBL21687526 0.88 KDM4E (0.33) METAP2KDM4EATML3MBTL1CYP1A2
SCHEMBL21688104 0.86 G6PD (0.32) METAP2KDM4ECYP1A2CYP3A4MEN1
SCHEMBL21687687 0.86 KDM4E (0.35) METAP2KDM4EATML3MBTL1CYP1A2
SCHEMBL21687682 0.85 KDM4E (0.37) METAP2KDM4EATML3MBTL1TDP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11201300-B2 Condensed cyclic compound and organic light-emitting device including condensed cyclic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-12-14 US disclosed
US-20200044168-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-02-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200044168-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND CRY1, CCNL2, CCNE2 METAP2 4740/4885KDM4E 2977/4885ATM 1151/4885
US-11201300-B2 Condensed cyclic compound and organic light-emitting device including condensed cyclic compound CRY1, CCNL2, CCNE2 METAP2 4740/4885KDM4E 2977/4885ATM 1151/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.